Anlotinib Active Not Recruiting Phase 2 / 3 Trials for Lung Cancer Non-Small Cell Cancer (NSCLC) Basic Science

IndicationsStatusPurposePhase
Active Not RecruitingBasic Science2 / 3
clinicaltrials.gov IdentifierTitleDrugs